GLICLAGLAZE TRIO 0.3 : usage, dosage, pictures and more information....

GLICLAGLAZE TRIO 0.3

Voglibose (0.3mg), Metformin (500mg), Gliclazide (80mg)

GLICLAGLAZE TRIO 0.3 is a combination medication used primarily for managing type 2 diabetes mellitus. This powerful formulation includes three key active ingredients: Voglibose (0.3mg), Metformin (500mg), and Gliclazide (80mg). Each of these components plays a vital role in controlling blood sugar levels, offering a multi-faceted approach to diabetes management. This article will provide a detailed overview of how GLICLAGLAZE TRIO 0.3 works, its benefits, dosage guidelines, potential side effects, and more.

Understanding the Components

Voglibose (0.3mg)

Voglibose is an alpha-glucosidase inhibitor that works by slowing down the breakdown of carbohydrates in the intestine, thereby reducing the postprandial (after meal) rise in blood glucose levels. By inhibiting the enzymes responsible for converting complex sugars into glucose, Voglibose helps to manage blood sugar levels more effectively, particularly after meals.

Metformin (500mg)

Metformin is one of the most commonly prescribed medications for type 2 diabetes. It works by decreasing glucose production in the liver and improving insulin sensitivity, which helps the body utilize insulin more effectively. This results in lower blood sugar levels both after meals and in the fasting state. Metformin is also known for its weight-neutral effect, making it a preferred choice for many patients.

Gliclazide (80mg)

Gliclazide belongs to the class of drugs known as sulfonylureas. It stimulates the pancreas to release more insulin, thereby helping to lower blood sugar levels. Gliclazide is particularly effective in controlling blood sugar spikes after meals. It also has antioxidant properties that may provide additional benefits in managing diabetes-related complications.

How Does GLICLAGLAZE TRIO 0.3 Work?

GLICLAGLAZE TRIO 0.3 combines the effects of Voglibose, Metformin, and Gliclazide to offer a comprehensive approach to managing type 2 diabetes. Here's how each component contributes:

• Voglibose slows down the digestion and absorption of carbohydrates, leading to a gradual rise in blood sugar levels post meals.
• Metformin reduces glucose production in the liver and improves insulin sensitivity, leading to better overall glucose control.
• Gliclazide increases insulin secretion from the pancreas, particularly after meals, to help reduce blood sugar spikes.

This combination allows for better glycemic control throughout the day, reducing the risk of both hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar).

Uses of GLICLAGLAZE TRIO 0.3

GLICLAGLAZE TRIO 0.3 is primarily used in the treatment of type 2 diabetes mellitus, particularly in patients who require a multi-pronged approach to control their blood sugar levels. It is especially beneficial for those who have not achieved adequate glycemic control with monotherapy or dual therapy and need a combination treatment to manage their condition effectively.

Dosage Guidelines

The dosage of GLICLAGLAZE TRIO 0.3 should be determined by a healthcare professional based on individual patient needs, existing medical conditions, and response to therapy. Generally, the medication is taken once or twice daily with meals to minimize gastrointestinal side effects and to ensure that the components work effectively in managing postprandial blood glucose levels.

• Voglibose (0.3mg): Helps in managing post-meal glucose spikes.
• Metformin (500mg): Provides sustained control over blood sugar levels throughout the day.
• Gliclazide (80mg): Ensures proper insulin release post meals to prevent sugar spikes.

Patients should follow their healthcare provider's instructions carefully and avoid altering the dosage without consultation.

Side Effects

Like all medications, GLICLAGLAZE TRIO 0.3 may cause side effects, although not everyone will experience them. Common side effects include:

• Gastrointestinal Issues: Nausea, vomiting, diarrhea, and abdominal pain are common, especially with Metformin and Voglibose. These side effects often improve as the body adjusts to the medication.
• Hypoglycemia: Due to Gliclazide, there is a risk of low blood sugar, particularly if meals are missed or if there is an unusual increase in physical activity without corresponding carbohydrate intake.
• Dizziness and Headache: These can occur as the body adapts to the medication, particularly in the initial stages of treatment.
• Allergic Reactions: Rarely, some individuals may experience allergic reactions such as rash, itching, or swelling.

It is essential to inform a healthcare provider of any side effects experienced while taking GLICLAGLAZE TRIO 0.3, particularly if they are severe or persistent.

Precautions and Safety Information

• Kidney Function: Since Metformin is eliminated through the kidneys, it is crucial to monitor kidney function regularly. GLICLAGLAZE TRIO 0.3 should be used with caution in patients with impaired kidney function.
• Liver Function: Patients with liver disease should use this medication cautiously and under strict medical supervision, as Gliclazide and Metformin can affect liver function.
• Cardiovascular Risk: Gliclazide may increase the risk of cardiovascular events in certain patients. Regular monitoring of heart function and blood pressure is advisable.
• Diet and Lifestyle: A balanced diet, regular exercise, and adherence to a diabetic-friendly lifestyle are essential for the effectiveness of GLICLAGLAZE TRIO 0.3. Patients should avoid excessive alcohol consumption as it can increase the risk of lactic acidosis with Metformin.
• Pregnancy and Breastfeeding: GLICLAGLAZE TRIO 0.3 should only be used during pregnancy or breastfeeding if prescribed by a healthcare provider, as the effects on the unborn child or nursing infant are not fully known.

Conclusion

GLICLAGLAZE TRIO 0.3 is a highly effective medication for managing type 2 diabetes, particularly in patients requiring a combination therapy approach. By leveraging the strengths of Voglibose, Metformin, and Gliclazide, this medication offers a comprehensive solution to controlling blood sugar levels throughout the day. However, it is essential to use this medication under the guidance of a healthcare provider, adhering to prescribed dosages and monitoring for any potential side effects. A healthy lifestyle, regular monitoring, and ongoing communication with a healthcare provider are crucial to achieving the best outcomes with GLICLAGLAZE TRIO 0.3. With proper management, patients can maintain better control over their diabetes and reduce the risk of long-term complications. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information 

Email: info@sterispharma.com /  contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488 

BUY NOW